Overview

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
Statins, a major class of drugs for treatment of hypercholesterolemia, are widely used due to a notable prevention of cardiovascular disease, and accumulating evidence proposes a promising role of statins in breast cancer
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Beni-Suef University
Collaborator:
Fayoum oncology Center
Treatments:
Atorvastatin